Shows
LabReflexShifting Hospital Needs and Inspection EvidenceInspection Prep: Documentation — What the Paper Trail Really SaysDocumentation isn’t paperwork. It’s system memory.Inspection anxiety often focuses on instruments, QC, and staff performance. But one of the most common reasons laboratories receive deficiencies has nothing to do with chemistry.It has to do with alignment.Your testing can be technically excellent. Your staff can be competent and conscientious. And you can still be cited — because the story your documentation tells does not match the system you’re actually running.In this ep...
2026-02-2331 min
LabReflexInspection PrepPre-Inspection Prep: Readiness Without PanicReadiness isn’t a binder. It’s a system.Inspection anxiety has a familiar rhythm.Suddenly policies are being printed. QC logs are double-checked. Everyone asks where the competency files are. It feels urgent — even if the inspector hasn’t arrived yet.But what does it actually mean to be “ready”?In this episode, we unpack a simple but powerful idea: inspection readiness is not about perfection. It’s about stability. The goal isn’t zero findings. The goal is a lab that behaves predicta...
2026-02-1632 min
LabReflexInspectors are coming! Inspectors are coming!Episode: The Inspection Is Coming: Now What?Release Date: February 9, 2026 When inspectors are on the calendar, anxiety rises fast — but inspections aren’t really about last-minute fixes or perfect binders. In this episode, Dr. Chris Zahner and Dr. Aakash reframe inspections for what they actually are: a stress test of laboratory systems, leadership, and documentation alignment.With rising Medicare scrutiny, new administrative requirements, and advance inspection notice now possible in many settings, this episode sets the foundation for how labs should think about inspection readiness in 2026.This Week’s Highlig...
2026-02-0928 min
LabReflexConference ConversationsIn this episode of LabReflex, we start with a few high-signal highlights from the past week before stepping back to ask a bigger question:Why does the future of laboratory medicine sound so different depending on which conference you attend?From workforce investments to seasonal flu pressure to high-consequence pathogens like Nipah virus, we explore what’s actually happening on the ground — and then unpack how conferences shape (and sometimes distort) the way we talk about it.This Week’s HighlightsThe Lab Workforce Story Is SplittingSome instit...
2026-02-0220 min
LabReflexWhen Numbers Feel Certain (But Aren’t Enough)Episode OverviewIn this episode of LabReflex, we step back from the question of what tests to order and focus instead on what it actually means when a laboratory result comes back with a single number that feels precise, authoritative, and actionable. Preventive cardiology has become very good at measuring risk, but much less consistent at explaining what that risk represents for an individual patient. Using ApoB and Lipoprotein(a) as concrete examples, this episode explores the growing gap between measurement and meaning, and why laboratories are increasingly being asked to help bridge it....
2026-01-2624 min
LabReflexPCR Leaves the Lab: How At-Home Molecular Testing Actually WorksEpisode OverviewIn this episode of LabReflex, we examine what it truly takes to move PCR out of the clinical laboratory and into the home. PCR chemistry itself hasn’t fundamentally changed; what’s changed is the system built around it. This episode focuses on the engineering, controls, and design decisions required to make molecular testing work reliably without trained technologists, controlled environments, or traditional lab workflows—and what that shift means for laboratories.Policy & Reimbursement Update — RESULTS Act / PAMAWe begin with a brief update on the recent House subcommittee hearing related to the RESULTS...
2026-01-1928 min
LabReflexPower Shifts: AI, Joint Ventures & the New Healthcare OrderEpisode OverviewIn this episode of LabReflex, Dr. Chris Zahner covers several key developments shaping clinical laboratories and healthcare in early 2026. The discussion begins with a brief update on the status of the RESULTS Act and what laboratory leaders should be watching next. From there, the episode explores the launch of ChatGPT Health and what expanding use of generative AI could mean for healthcare decision-making. The conversation then turns to recent diagnostic joint ventures and partnerships, before closing with a set of quick housekeeping updates and notable industry headlines.Segment 1: RESULTS Act — Where Things Stand...
2026-01-1216 min
LabReflexYear in reviewLabReflex 2025 Year in ReviewPractical progress in an uncertain yearAs 2025 comes to a close, LabReflex takes a step back to reflect on what actually shaped clinical laboratories this year. This episode is not about big promises or dramatic breakthroughs. It is about how labs responded in practical ways to persistent pressure.Rather than solving long standing problems, many organizations focused on setting reasonable goals, stabilizing operations, and making incremental improvements where they could. In many ways, that mindset defined the year.Workforce strain as a permanent conditionStaffing...
2025-12-2224 min
LabReflexCAP Changes and New InnovationsLabReflex Podcast – Episode NotesEpisode Title: Modern Lab Transitions: CAP’s 2025 Overhaul, Reliable AI, and Diagnostics on the Front Line Host: Dr. Chris Zahner and Dr. AakashEpisode SummaryThis episode examines the major shifts coming to clinical laboratories as CAP releases its most consequential checklist updates in years. Digital pathology, remote review, and self-collected specimens are now positioned as core operational elements rather than edge capabilities, and we break down what laboratories must understand before their next inspection cycle. We then explore a new AI methodology from Johns Hopkins, know...
2025-12-1525 min
LabReflexThe Four Forces Shaping the Lab this weekLabReflex Show NotesEpisode Title: Diagnostics at a Crossroads: Four Forces Reshaping the Future of Labs Hosts: Chris Zahner and Aakash Episode Type: Industry analysis and strategic discussionSummaryIn this episode, we break down four major forces reshaping the clinical laboratory landscape right now:Automation and the redistribution of diagnostic work.Genomics as a business driver rather than a niche specialty.Regulators pushing healthcare toward biomarker-defined disease.Instability across the healthcare system — including payer disputes, hospital closures, and laboratory consolidation.We connect these trends to real de...
2025-12-0841 min
LabReflexWorkforce and AI GovernanceShow notes1. Workforce First We begin by tackling the workforce crisis in the clinical lab world: new data show 1 in 4 healthcare workers are considering leaving the industry — and our labs are not immune. What does that mean for QC, turnaround times, validation, and staffing resilience? We walk through actionable steps labs can take today — from cross-training to automation prioritization and career ladder improvements.2. AI Governance Gaps Next: why AI is being adopted everywhere but few labs are ready. We reference CAP’s AI Committee and its charge to “create and maintain an AI strategy...
2025-11-2425 min
LabReflexGovernment Returns!Government Returns!Episode Summary:In this episode of LabReflex, Dr. Chris Zahner breaks down four major developments every laboratory should be watching closely. The federal government is open again after the longest shutdown in U.S. history — but agencies are not fully back to normal. At the same time, severe global flu activity is signaling a challenging U.S. season, host-response diagnostics are advancing rapidly (including UTMB’s own TriVerity validation study), and the FDA’s new fast-track pathway for personalized therapies is poised to shift significant workload onto clinical labs.This s...
2025-11-1712 min
LabReflexGovernment Shutdown...Summary: This week, we explore two powerful forces shaping the future of clinical laboratories — the policy storm around the RESULTS Act vs. PAMA and the economic slowdown rippling through major IVD and automation vendors. Together, they reveal how reimbursement pressure and upstream supply constraints could redefine what stability looks like for hospital and independent labs alike.Segments:The RESULTS Act & PAMA Cliff – What Congress is trying to fix, what happens if they don’t, and how labs can model 2026 scenarios now.Vendor Slowdown & Supply Chain Shifts – What’s driving slower product rollouts, higher reagent costs, and what l...
2025-11-1108 minLabReflexIntroductionIn this inaugural episode of LabReflex, host Dr. Chris Zahner sets the stage for what this podcast is all about: bringing clarity, curiosity, and clinical relevance to the world of laboratory medicine. Whether you're a pathologist, laboratorian, clinician, or health tech enthusiast, this episode gives you a preview of what’s to come:Why reflex testing, stewardship, and decision support matterHow the lab can lead (not just support) clinical careWhat to expect from future episodes — including interviews, real-world stories, and bold ideasThis is your backstage pass to a high-impact, low-bull podcast that’s smart, efficient, and worth...
2025-06-1803 min
A Word With Bob: RBMA's Official PodcastEp. 31: Dr. Christopher Zahner & Dr. Eric Walser; Michael Young
2024-03-041h 00